{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:22:53Z","timestamp":1793218973750,"version":"4.5.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.gendis.2025.101719","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:21:15Z","timestamp":1749558075000},"page":"101719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging"],"prefix":"10.1016","volume":"13","author":[{"given":"Tingting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gendis.2025.101719_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/14737175.2015.1038244","article-title":"Parkinson's disease: a review of non-motor symptoms","volume":"15","author":"Rana","year":"2015","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1155\/2011\/143857","article-title":"Emotional dysfunction in Parkinson's disease","volume":"24","author":"Blonder","year":"2011","journal-title":"Behav Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.gendis.2025.101719_bib3","first-page":"66","article-title":"Association between bipolar disorder and Parkinson's disease","volume":"35","author":"Geelhand de Merxem","year":"2023","journal-title":"Psychiatr Danub"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000116245","article-title":"Tuberoinfundibular dopaminergic function in Parkinson's disease","volume":"28","author":"Franceschi","year":"1988","journal-title":"Eur Neurol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101719_bib5","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3233\/JPD-223363","article-title":"Unraveling Parkinson's disease neurodegeneration: does aging hold the clues?","volume":"12","author":"Coleman","year":"2022","journal-title":"J Parkinsons Dis"},{"issue":"7","key":"10.1016\/j.gendis.2025.101719_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/mds.27037","article-title":"Aging and Parkinson's disease: different sides of the same coin?","volume":"32","author":"Collier","year":"2017","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afad186","article-title":"New horizons in Parkinson's disease in older populations","volume":"52","author":"Chhetri","year":"2023","journal-title":"Age Ageing"},{"key":"10.1016\/j.gendis.2025.101719_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2360872","article-title":"Oxidative stress in Parkinson's disease: potential benefits of antioxidant supplementation","volume":"2020","author":"Perc\u00e1rio","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/j.gendis.2025.101719_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ncl.2020.08.003","article-title":"Toxin-induced parkinsonism","volume":"38","author":"McKnight","year":"2020","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.gendis.2025.101719_bib10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12575-024-00236-3","article-title":"Targeting mitochondrial complex I deficiency in MPP+\/MPTP-induced Parkinson's disease cell culture and mouse models by transducing yeast NDI1 gene","volume":"26","author":"Li","year":"2024","journal-title":"Biol Proced Online"},{"issue":"5","key":"10.1016\/j.gendis.2025.101719_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.32604\/biocell.2024.049130","article-title":"Pathogenic genes associated with Parkinson's disease: molecular mechanism overview","volume":"48","author":"Liu","year":"2024","journal-title":"Biocell"},{"issue":"9","key":"10.1016\/j.gendis.2025.101719_bib13","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1111\/ejn.14699","article-title":"Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: implications for Parkinson's disease","volume":"53","author":"Feng","year":"2021","journal-title":"Eur J Neurosci"},{"issue":"8","key":"10.1016\/j.gendis.2025.101719_bib14","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.3390\/ijms25084187","article-title":"DNA damage and Parkinson's disease","volume":"25","author":"Pfeifer","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00401-011-0902-3","article-title":"Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease","volume":"123","author":"Pilsl","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101719_bib17","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","article-title":"Mitochondrial quality control in health and in Parkinson's disease","volume":"102","author":"Eldeeb","year":"2022","journal-title":"Physiol Rev"},{"key":"10.1016\/j.gendis.2025.101719_bib18","first-page":"34","article-title":"Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease","volume":"2","author":"Navarro","year":"2010","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101719_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.gendis.2025.101719_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134296","article-title":"Oxidative stress and Parkinson's disease: conflict of oxidant-antioxidant systems","volume":"709","author":"Hemmati-Dinarvand","year":"2019","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib22","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/ijms24033022","article-title":"Oxidative stress and aging as risk factors for Alzheimer's disease and Parkinson's disease: the role of the antioxidant melatonin","volume":"24","author":"Tchekalarova","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/bbrc.1997.6132","article-title":"DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras","volume":"231","author":"Nagakubo","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"5604","key":"10.1016\/j.gendis.2025.101719_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science."},{"issue":"4","key":"10.1016\/j.gendis.2025.101719_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/cells13040296","article-title":"Pathogenesis of DJ-1\/PARK7-mediated Parkinson's disease","volume":"13","author":"Skou","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.gendis.2025.101719_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson's disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3233\/JPD-230357","article-title":"Parkinson's disease is predominantly an environmental disease","volume":"14","author":"Dorsey","year":"2024","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib28","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1074\/jbc.M210432200","article-title":"Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production","volume":"278","author":"Li","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gendis.2025.101719_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102667","article-title":"Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders","volume":"104","author":"Wen","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1039\/c2mt20164j","article-title":"Metallobiology of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity","volume":"5","author":"Hare","year":"2013","journal-title":"Metallomics"},{"issue":"9","key":"10.1016\/j.gendis.2025.101719_bib31","article-title":"Mitochondria in neuronal health: from energy metabolism to Parkinson's disease","volume":"5","author":"Murali Mahadevan","year":"2021","journal-title":"Adv Bio Tech"},{"issue":"8","key":"10.1016\/j.gendis.2025.101719_bib32","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/1873-3468.13995","article-title":"Mitochondrial disorders of the OXPHOS system","volume":"595","author":"Fernandez-Vizarra","year":"2021","journal-title":"FEBS Lett"},{"key":"10.1016\/j.gendis.2025.101719_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104495","article-title":"The unresolved role of mitochondrial DNA in Parkinson's disease: an overview of published studies, their limitations, and future prospects","volume":"129","author":"M\u00fcller-Nedebock","year":"2019","journal-title":"Neurochem Int"},{"key":"10.1016\/j.gendis.2025.101719_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-030-55035-6_4","article-title":"Parkinson's disease and impairment in mitochondrial metabolism: a pathognomic signature","volume":"1286","author":"Das","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"Pt A","key":"10.1016\/j.gendis.2025.101719_bib35","article-title":"From mitochondrial dysfunction to neuroinflammation in Parkinson's disease: pathogenesis and mitochondrial therapeutic approaches","volume":"142","author":"Ebadpour","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","article-title":"PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation","volume":"8","author":"Quinn","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.gendis.2025.101719_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neures.2020.01.006","article-title":"The PINK1-parkin axis: an overview","volume":"159","author":"Tanaka","year":"2020","journal-title":"Neurosci Res"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1515\/revneuro-2022-0056","article-title":"Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases","volume":"34","author":"Shi","year":"2022","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.gendis.2025.101719_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104553","article-title":"Dynamin-related protein 1: a protein critical for mitochondrial fission, mitophagy, and neuronal death in Parkinson's disease","volume":"151","author":"Feng","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.gendis.2025.101719_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mito.2022.02.003","article-title":"Fighting Parkinson\u2019s disease: the return of the mitochondria","volume":"64","author":"Zambrano","year":"2022","journal-title":"Mitochondrion"},{"key":"10.1016\/j.gendis.2025.101719_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","article-title":"Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease","volume":"62","author":"Yan","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.gendis.2025.101719_bib43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fnins.2019.00930","article-title":"Intracellular and intercellular mitochondrial dynamics in Parkinson's disease","volume":"13","author":"Valdinocci","year":"2019","journal-title":"Front Neurosci"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","article-title":"The role of PINK1-Parkin in mitochondrial quality control","volume":"26","author":"Narendra","year":"2024","journal-title":"Nat Cell Biol"},{"issue":"16","key":"10.1016\/j.gendis.2025.101719_bib45","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/hmg\/ddr235","article-title":"The PINK1\/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons","volume":"20","author":"Yu","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib46","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/biom11101508","article-title":"Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery","volume":"11","author":"Picca","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.gendis.2025.101719_bib47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2412029122","article-title":"Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain","volume":"122","author":"Bagnoli","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gendis.2025.101719_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mito.2021.12.006","article-title":"Standpoints in mitochondrial dysfunction: underlying mechanisms in search of therapeutic strategies","volume":"63","author":"Videla","year":"2022","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25464-z","article-title":"A novel small molecule inhibitor of human Drp1","volume":"12","author":"Rosdah","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12967-023-04270-9","article-title":"Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization","volume":"21","author":"Su","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib51","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s13287-021-02656-4","article-title":"PINK1 deficiency impairs osteoblast differentiation through aberrant mitochondrial homeostasis","volume":"12","author":"Lee","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib52","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210255","article-title":"Selective localization of Mfn2 near PINK1 enables its preferential ubiquitination by Parkin on mitochondria","volume":"12","author":"Vranas","year":"2022","journal-title":"Open Biol"},{"issue":"5","key":"10.1016\/j.gendis.2025.101719_bib53","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/ijms21051772","article-title":"PINK1\/parkin mediated mitophagy, Ca2+ signalling, and ER-mitochondria contacts in Parkinson's disease","volume":"21","author":"Barazzuol","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib54","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41467-017-01435-1","article-title":"PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib55","doi-asserted-by":"crossref","first-page":"8395","DOI":"10.3390\/cimb45100529","article-title":"Mitochondrial dysfunction in dopaminergic neurons derived from patients with LRRK2- and SNCA-associated genetic forms of Parkinson's disease","volume":"45","author":"Vetchinova","year":"2023","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101719_bib56","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1096\/fj.201802628R","article-title":"Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus","volume":"33","author":"Mallach","year":"2019","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.gendis.2025.101719_bib57","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s12264-021-00732-6","article-title":"Co-editing PINK1 and DJ-1 genes via adeno-associated virus-delivered CRISPR\/Cas9 system in adult monkey brain elicits classical parkinsonian phenotype","volume":"37","author":"Li","year":"2021","journal-title":"Neurosci Bull"},{"issue":"s1","key":"10.1016\/j.gendis.2025.101719_bib58","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.3233\/JPD-223277","article-title":"Blood and cerebrospinal fluid biomarkers of inflammation in Parkinson's disease","volume":"12","author":"Zimmermann","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.gendis.2025.101719_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.scr.2018.01.022","article-title":"Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene","volume":"28","author":"Marote","year":"2018","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.gendis.2025.101719_bib60","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fnhum.2019.00306","article-title":"G2019S variation in LRRK2: an ideal model for the study of Parkinson's disease?","volume":"13","author":"Ren","year":"2019","journal-title":"Front Hum Neurosci"},{"issue":"5","key":"10.1016\/j.gendis.2025.101719_bib61","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","article-title":"Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S","volume":"30","author":"Li","year":"2010","journal-title":"J Neurosci"},{"issue":"7425","key":"10.1016\/j.gendis.2025.101719_bib62","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11557","article-title":"Progressive degeneration of human neural stem cells caused by pathogenic LRRK2","volume":"491","author":"Liu","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib63","article-title":"Targeting LRRK2 in Parkinson's disease","volume":"3","author":"Xiao","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.gendis.2025.101719_bib64","article-title":"PARK genes link mitochondrial dysfunction and alpha-synuclein pathology in sporadic Parkinson's disease","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2025.101719_bib65","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S1353-8020(11)70023-2","article-title":"Molecular pathways in sporadic PD","volume":"18","author":"Valente","year":"2012","journal-title":"Parkinsonism Relat Disorders"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib66","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1038\/s41380-021-01207-w","article-title":"PIAS2-mediated blockade of IFN-\u03b2 signaling: a basis for sporadic Parkinson disease dementia","volume":"26","author":"Magalhaes","year":"2021","journal-title":"Mol Psychiatr"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib67","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2015.08.069","article-title":"Lack of neuronal IFN-\u03b2-IFNAR causes lewy body- and Parkinson's disease-like dementia","volume":"163","author":"Ejlerskov","year":"2015","journal-title":"Cell"},{"issue":"50","key":"10.1016\/j.gendis.2025.101719_bib68","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.1704351114","article-title":"SUMOylation and ubiquitination reciprocally regulate \u03b1-synuclein degradation and pathological aggregation","volume":"114","author":"Rott","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.gendis.2025.101719_bib69","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.26209","article-title":"Neuronal TNF\u03b1, not \u03b1-syn, underlies PDD-like disease progression in IFN\u03b2-KO mice","volume":"90","author":"Villanueva","year":"2021","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib70","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.gendis.2025.101719_bib71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410300409","article-title":"Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease","volume":"30","author":"Hattori","year":"1991","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101719_bib72","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2025.101719_bib73","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0304-3940(94)90372-7","article-title":"Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars Compacta of patients with Parkinson's disease","volume":"169","author":"Janetzky","year":"1994","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib74","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1038\/s41467-020-17876-0","article-title":"A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders","volume":"11","author":"Agarwal","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s42003-021-02973-7","article-title":"Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson's disease","volume":"5","author":"Novak","year":"2022","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib76","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s12035-024-04419-7","article-title":"Single-cell cortical transcriptomics reveals common and distinct changes in cell-cell communication in Alzheimer's and Parkinson's disease","volume":"62","author":"Le Bars","year":"2025","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib77","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12883-019-1276-8","article-title":"Characterizing advanced Parkinson's disease: observe-PD observational study results of 2615 patients","volume":"19","author":"Fasano","year":"2019","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s10020-022-00456-x","article-title":"Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo","volume":"28","author":"Li","year":"2022","journal-title":"Mol Med"},{"issue":"8006","key":"10.1016\/j.gendis.2025.101719_bib79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","article-title":"Mitochondrial complex I activity in microglia sustains neuroinflammation","volume":"628","author":"Peruzzotti-Jametti","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib80","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.410300304","article-title":"Mitochondrial oxidative phosphorylation defects in Parkinson's disease","volume":"30","author":"Shoffner","year":"1991","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.gendis.2025.101719_bib81","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1212\/WNL.43.11.2258","article-title":"Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease","volume":"43","author":"Cardellach","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.gendis.2025.101719_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101939","article-title":"The multifactorial nature of healthy brain ageing: brain changes, functional decline and protective factors","volume":"88","author":"Turrini","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.gendis.2025.101719_bib83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-cellbio-120420-015303","article-title":"Mitochondria as cellular and organismal signaling hubs","volume":"38","author":"Shen","year":"2022","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib84","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12964-024-01663-1","article-title":"Molecular mechanisms of aging and anti-aging strategies","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.gendis.2025.101719_bib85","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.12659\/MSM.902515","article-title":"Aging reversal and healthy longevity is in reach: dependence on mitochondrial DNA heteroplasmy as a key molecular target","volume":"23","author":"Stefano","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.gendis.2025.101719_bib86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.exger.2016.07.010","article-title":"Mitochondrial DNA plays an equal role in influencing female and male longevity in centenarians","volume":"83","author":"He","year":"2016","journal-title":"Exp Gerontol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib87","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/acel.12312","article-title":"Parkinson's disease as a result of aging","volume":"14","author":"Rodriguez","year":"2015","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/cells9010017","article-title":"Mitochondrial gene expression and beyond-novel aspects of cellular physiology","volume":"9","author":"Kotrys","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.gendis.2025.101719_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117084","article-title":"New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases","volume":"178","author":"Chen","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"10.1016\/j.gendis.2025.101719_bib90","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","article-title":"Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis","volume":"1792","author":"Banerjee","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/j.gendis.2025.101719_bib91","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2174\/1871527322666230609141519","article-title":"Oxidative stress and dopaminergic metabolism: a major PD pathogenic mechanism and basis of potential antioxidant therapies","volume":"23","author":"Rasool","year":"2024","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.gendis.2025.101719_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.826193","article-title":"Evidence that substantia nigra pars Compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active","volume":"16","author":"Ni","year":"2022","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.gendis.2025.101719_bib93","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.gendis.2025.101719_bib94","first-page":"86","article-title":"Oxidative stress, mitochondrial dysfunction and the mitochondria theory of aging","volume":"39","author":"Kong","year":"2014","journal-title":"Interdiscipl Top Gerontol"},{"key":"10.1016\/j.gendis.2025.101719_bib95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchemneu.2017.12.004","article-title":"Reinforcing mitochondrial functions in aging brain: an insight into Parkinson's disease therapeutics","volume":"95","author":"Chandra","year":"2019","journal-title":"J Chem Neuroanat"},{"issue":"6131","key":"10.1016\/j.gendis.2025.101719_bib96","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.1231031","article-title":"PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria","volume":"340","author":"Chen","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.gendis.2025.101719_bib97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2016.11.003","article-title":"NAD and the aging process: role in life, death and everything in between","volume":"455","author":"Chini","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.gendis.2025.101719_bib98","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuroscience.2022.07.007","article-title":"Age-related mitochondrial dysfunction in Parkinson's disease: new insights into the disease pathology","volume":"499","author":"Rani","year":"2022","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.gendis.2025.101719_bib99","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1089\/dna.2019.5347","article-title":"Mitochondrial and nuclear DNA oxidative damage in physiological and pathological aging","volume":"39","author":"Kowalska","year":"2020","journal-title":"DNA Cell Biol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101719_bib100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1179\/1743132813Y.0000000296","article-title":"Increased vulnerability with aging to MPTP: the mechanisms underlying mitochondrial dynamics","volume":"36","author":"Jiang","year":"2014","journal-title":"Neurol Res"},{"issue":"24 Pt A","key":"10.1016\/j.gendis.2025.101719_bib101","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","article-title":"Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease","volume":"589","author":"Haddad","year":"2015","journal-title":"FEBS Lett"},{"key":"10.1016\/j.gendis.2025.101719_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101955","article-title":"Mitochondrial dysfunction in aging","volume":"88","author":"Guo","year":"2023","journal-title":"Ageing Res Rev"},{"issue":"4","key":"10.1016\/j.gendis.2025.101719_bib103","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","article-title":"Mitochondrial and metabolic dysfunction in ageing and age-related diseases","volume":"18","author":"Amorim","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.gendis.2025.101719_bib104","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","article-title":"Microglia development and function","volume":"32","author":"Nayak","year":"2014","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia biology: one century of evolving concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2025.101719_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997786","article-title":"Microglia morphophysiological diversity and its implications for the CNS","volume":"13","author":"Vidal-Itriago","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2025.101719_bib107","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-981-13-9913-8_13","article-title":"Microglia in Parkinson's disease","volume":"1175","author":"Ho","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib108","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pharmthera.2013.04.013","article-title":"Microglia during development and aging","volume":"139","author":"Harry","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib109","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41420-024-01816-8","article-title":"Glial senescence enhances \u03b1-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction","volume":"10","author":"Hong","year":"2024","journal-title":"Cell Death Discov"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib110","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"145","author":"Smaji\u0107","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib111","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10571-024-01528-8","article-title":"Aging and MPTP sensitivity depend on molecular and ultrastructural signatures of astroglia and microglia in mice substantia nigra","volume":"45","author":"Abhilash","year":"2025","journal-title":"Cell Mol Neurobiol"},{"issue":"31","key":"10.1016\/j.gendis.2025.101719_bib112","article-title":"Cordycepin modulates microglial M2 polarization coupled with mitochondrial metabolic reprogramming by targeting HKII and PDK2","volume":"11","author":"Zhong","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.gendis.2025.101719_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.795036","article-title":"Targeting TREM2 for Parkinson's disease: where to go?","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00479","article-title":"Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation","volume":"22","author":"Li","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.gendis.2025.101719_bib115","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1096\/fj.201900992R","article-title":"TREM2 deficiency aggravates \u03b1-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib116","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/ijms19010318","article-title":"Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes","volume":"19","author":"Mecca","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.gendis.2025.101719_bib117","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.15252\/embr.201743922","article-title":"TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury","volume":"18","author":"Mazaheri","year":"2017","journal-title":"EMBO Rep"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib118","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s43587-023-00479-x","article-title":"Transcriptional and epigenetic decoding of the microglial aging process","volume":"3","author":"Li","year":"2023","journal-title":"Nat Aging"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib119","doi-asserted-by":"crossref","first-page":"254","DOI":"10.14336\/AD.2019.0615","article-title":"Disease progression-dependent expression of CD200R1 and CX3CR1 in mouse models of Parkinson's disease","volume":"11","author":"Wang","year":"2020","journal-title":"Aging Dis"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib120","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/cells9102277","article-title":"The impact of the CX3CL1\/CX3CR1 axis in neurological disorders","volume":"9","author":"Pawelec","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib121","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/cells10102648","article-title":"Antibiotics treatment modulates microglia-synapses interaction","volume":"10","author":"Cordella","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib122","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib123","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/j.gendis.2025.101719_bib124","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.3390\/ijms25189975","article-title":"New insights into mitochondria in health and diseases","volume":"25","author":"Li","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.gendis.2025.101719_bib125","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/antiox12051117","article-title":"Escalating bi-directional feedback loops between proinflammatory microglia and mitochondria in ageing and post-diagnosis of Parkinson's disease","volume":"12","author":"Ravenhill","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.gendis.2025.101719_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137262","article-title":"Alteration in mitochondrial dynamics promotes the proinflammatory response of microglia and is involved in cerebellar dysfunction of young and aged mice following LPS exposure","volume":"807","author":"Ghosh","year":"2023","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2009.02.001","article-title":"Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging","volume":"201","author":"Nakanishi","year":"2009","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.gendis.2025.101719_bib128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7555\/JBR.37.20220220","article-title":"Microglia in brain aging: an overview of recent basic science and clinical research developments","volume":"38","author":"Fan","year":"2024","journal-title":"J Biomed Res"},{"issue":"9","key":"10.1016\/j.gendis.2025.101719_bib129","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.3390\/ijms22094956","article-title":"Epigenetic regulation of neuroinflammation in Parkinson's disease","volume":"22","author":"Rasheed","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.gendis.2025.101719_bib130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41401-022-01030-1","article-title":"Pazopanib alleviates neuroinflammation and protects dopaminergic neurons in LPS-stimulated mouse model by inhibiting MEK4-JNK-AP-1 pathway","volume":"44","author":"Sun","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.gendis.2025.101719_bib131","article-title":"Compound Dihuang Granule inhibits nigrostriatal pathway apoptosis in Parkinson's disease by suppressing the JNK\/AP-1 pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101719_bib132","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/ene.14918","article-title":"P2X7 receptor\/NLRP3 inflammasome complex and \u03b1-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-na\u00efve Parkinson's disease","volume":"28","author":"Solini","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.gendis.2025.101719_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107962","article-title":"JNK inhibition alleviates delayed neurocognitive recovery after surgery by limiting microglia pyroptosis","volume":"99","author":"He","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101719_bib134","doi-asserted-by":"crossref","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Normal aging induces A1-like astrocyte reactivity","volume":"115","author":"Clarke","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.gendis.2025.101719_bib135","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cells9122623","article-title":"Neuron-astrocyte interactions in Parkinson's disease","volume":"9","author":"Miyazaki","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.gendis.2025.101719_bib136","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","article-title":"Glutamate-induced excitotoxicity in Parkinson's disease: the role of glial cells","volume":"144","author":"Iovino","year":"2020","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.gendis.2025.101719_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.668517","article-title":"Astrocyte-neuron metabolic crosstalk in neurodegeneration: a mitochondrial perspective","volume":"12","author":"Mulica","year":"2021","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib138","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13024-023-00672-x","article-title":"Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders","volume":"18","author":"Huang","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.gendis.2025.101719_bib139","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81943","article-title":"Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice","volume":"11","author":"Szego","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.gendis.2025.101719_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115093","article-title":"Suppression of cGAS\/STING pathway-triggered necroptosis in the hippocampus relates H2S to attenuate cognitive dysfunction of Parkinson's disease","volume":"385","author":"Huang","year":"2025","journal-title":"Exp Neurol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib141","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41418-023-01216-y","article-title":"The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson's disease via LCN2-dependent astrocyte senescence","volume":"30","author":"Jiang","year":"2023","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib142","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12974-017-1018-z","article-title":"Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes","volume":"14","author":"Gustafsson","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.gendis.2025.101719_bib143","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mito.2018.12.002","article-title":"Increased energetic demand supported by mitochondrial electron transfer chain and astrocyte assistance is essential to maintain the compensatory ability of the dopaminergic neurons in an animal model of early Parkinson\u2019s disease","volume":"47","author":"Kuter","year":"2019","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.gendis.2025.101719_bib144","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cns.13982","article-title":"Brain energy metabolism: astrocytes in neurodegenerative diseases","volume":"29","author":"Chen","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.gendis.2025.101719_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.608026","article-title":"Mitochondrial dysfunction in astrocytes: a role in Parkinson's disease?","volume":"8","author":"Bantle","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101719_bib146","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1007\/s11064-021-03239-8","article-title":"Astrocyte mitochondria in white-matter injury","volume":"46","author":"Nguyen","year":"2021","journal-title":"Neurochem Res"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225002089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225002089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:03:56Z","timestamp":1767042236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":146,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2352304225002089"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101719","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101719"}}